Skip to content

Lidocaine as an adjuvant to propofol sedation for same-visit bidirectional endoscopy: A prospective, multicenter, randomized, controlled trial

Lidocaine as an adjuvant to propofol sedation for same-visit bidirectional endoscopy: A prospective, multicenter, randomized, controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087583
Enrollment
Unknown
Registered
2024-07-30
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

normal saline group:Sufentanil 0.1µg/kg, saline equivalent to lidocaine, propofol 1.0mg/kg were administered in sequence, followed by additional propofol as needed during the examination
lidocaine group:Sufentanil was administered 0.1µg/kg, lidocaine 1.5mg/kg, and propofol 1.0mg/kg, followed by additional propofol as needed during the examination.

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 65 to 80 years; 2. ASA physical status I to III; 3. BMI 18-30 kg/m^2; 4. Scheduled for same-visit bidirectional endoscopy under sedation.

Exclusion criteria

Exclusion criteria: 1. Patients with endoscopic operation contraindications or refusal of anesthesia. 2. Uncontrolled circulatory and respiratory diseases that may threaten life, such as acute coronary syndrome, uncontrolled severe hypertension (systolic blood pressure =180mmHg, diastolic blood pressure =110mmHg), severe arrhythmia, heart failure, acute respiratory infection, asthma attack, active massive hemoptysis, Liver dysfunction (Child-Pugh grade C or above), acute upper gastrointestinal bleeding with shock, severe anemia (Hb<6g/dl), gastrointestinal obstruction with gastric content retention. 3. Without an escort or guardian. 4. Have sedation or anesthesia drug allergy or patients with severe allergic history and family history.

Design outcomes

Primary

MeasureTime frame
a composite outcome of desaturation and hypotension;

Secondary

MeasureTime frame
total dose of propofol;pain scores;fatigue scores;Body movement response;recovery time;

Countries

China

Contacts

Public ContactFuhai Ji

The First Affiliated Hospital of Soochow University

jifuhai@hotmail.com+86 136 5620 7331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026